|
⚲
|
| Andrew Koven | |
|---|---|
| Firm | |
| Address | 545 Concord Avenue Suite 210 Cambridge, Ma 02138 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM ($M) |
|---|---|---|---|---|---|
| Metavia Inc | 021-546292 | Director | 10.0 M of 10.0 M |
||
| Kala Bio Inc | 021-533926 | Director | 10.7 M of 10.7 M |
||
| Neurobo Pharmaceuticals Inc | 021-517518 | Director | 17.0 M of 17.0 M |
||
| Kala Bio Inc | 021-517395 | Director | 12.5 M of 12.5 M |
||
| Kala Pharmaceuticals Inc | 021-422740 | Director | 16.1 M of 36.5 M |
||
| Neurobo Pharmaceuticals Inc | 021-417342 | Director | 14.0 M of 14.0 M |
||
| Aralez Pharmaceuticals Inc | 021-257798 | Executive Officer | 75.0 M of 75.0 M |
||
| Tribute Pharmaceuticals Canada Inc | 021-256900 | Executive Officer | 75.0 M of 75.0 M |
||
| Tribute Pharmaceuticals Canada Inc | 021-256901 | Executive Officer | 75.0 M of 75.0 M |
||